Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil
1 other identifier
observational
650
1 country
24
Brief Summary
The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult survivors of hospitalization for COVID-19. Adult patients requiring hospitalization due to COVID-19 disease will be followed through structured and centralized telephone interviews performed at 3, 6, 9 and 12 months after enrollment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Typical duration for all trials
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedStudy Start
First participant enrolled
December 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedNovember 7, 2023
November 1, 2023
2.3 years
December 20, 2021
November 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
One-year utility score of health related quality of life
The outcome will be assessed using the Brazilian version of the Euroqol-5D-3L (EQ-5D3L) questionnaire.
The outcome will be assessed 12 months after enrollment.
Secondary Outcomes (12)
Utility score of health related quality of life at 3, 6, and 9 months
The outcome will be assessed at 3, 6, and 9 months after enrollment.
Incidence of all-cause mortality
The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.
Incidence of major cardiovascular events
The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.
Incidence of rehospitalizations
The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.
Prevalence of prolonged COVID-19 symptoms
The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.
- +7 more secondary outcomes
Study Arms (1)
Hospitalized COVID-19 patients
Hospitalized COVID-19 patients
Interventions
Eligibility Criteria
Adult patients survivors of hospitalization due to proven COVID-19 disease.
You may qualify if:
- Age ≥18 years;
- Symptomatic COVID-19 disease within the last 14 days;
- Positive polymerase chain reaction (PCR) test for SARS-CoV-2 within the last 14 days;
- Need of hospitalization (duration ≥ 48 hours).
You may not qualify if:
- Severe comorbidity with life expectancy less than 3 months;
- Death during hospitalization;
- Absence of telephone contact;
- Absence of proxy for patients with communication difficulties;
- Refusal or withdrawal of agreement to participate;
- Previous enrollment in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
Hospital do Coração de Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Hospital das clínicas da UFMG
Belo Horizonte, Minas Gerais, Brazil
Hospital Emydio Germano
Belo Horizonte, Minas Gerais, Brazil
Hospital Metropolitano Célio de Castro
Belo Horizonte, Minas Gerais, Brazil
Instituto Horizonti
Belo Horizonte, Minas Gerais, Brazil
Santa Casa de Curitiba
Curitiba, Paraná, Brazil
Hospital Universitário de Londrina
Londrina, Paraná, Brazil
Hospital universitário de Ponta Grossa
Ponta Grossa, Paraná, Brazil
Hospital Universitário de Canoas
Canoas, Rio Grande do Sul, Brazil
Hospital Nelson Cornetet
Guaíba, Rio Grande do Sul, Brazil
Hospital das Clínicas de Passo Fundo
Passo Fundo, Rio Grande do Sul, Brazil
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
Fundação Universitária Instituto de Cardiologia
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Ernesto Dornelles
Porto Alegre, Rio Grande do Sul, Brazil
Hospital moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Vila Nova
Porto Alegre, Rio Grande do Sul, Brazil
Cemetron
Porto Velho, Rondônia, Brazil
Hospital Leo Orsi
Itapetininga, São Paulo, Brazil
Hospital Beneficência Portuguesa de Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil
Hospital Alemão Oswaldo Cruz
São Paulo, São Paulo, Brazil
Hospital Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil
Hospital do Coração
São Paulo, São Paulo, Brazil
Hospital SEPACO
São Paulo, São Paulo, Brazil
Related Publications (1)
Trott G, Scolari FL, Rover MM, Silva MMDD, Souza D, Santos RDRMD, Schardosim RFC, Rech GS, Mesquita Neto J, Estivalete GP, Freitas HJM, Itaqui CR, Kozesinski-Nakatani AC, Biolo A, Marcolino MS, Barreto BB, Schvartzman PR, Antonio ACP, Robinson CC, Falavigna M, Polanczyk CA, Rosa RG. Long-term Health-Related Quality of Life and Outcomes after Hospitalization for COVID-19 in Brazil: Post-COVID Brazil 1 Study Protocol. Arq Bras Cardiol. 2023 Nov;120(11):e20230378. doi: 10.36660/abc.20230378. English, Portuguese.
PMID: 37991122DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Regis G Rosa, MD, PhD
Hospital Moinhos de Vento
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2021
First Posted
December 21, 2021
Study Start
December 21, 2021
Primary Completion
April 1, 2024
Study Completion
July 1, 2024
Last Updated
November 7, 2023
Record last verified: 2023-11